Cleopatra Hospital is trading at $18.09, up 3.97%, with no clear catalyst identified.

  • No company-specific announcement dated August 9, 2026, or during the August 7 session was identified in available company and market coverage.
  • Recent results point to earlier financial and expansion news, including the Sky hospital opening and Q1 revenue growth, but neither is explicitly linked to the move.
  • U.S. market futures were positive, while provided major-index readings were flat; a global catalyst is not sufficiently established.